Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

McKesson Corp (NY: MCK )

603.32 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Feb 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about McKesson Corp

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
18 19 Next >
Bear Market Investing: Should You Buy Today's Top Performers?
Some stocks are defying the bear market. 
Via The Motley Fool
5 Analysts Have This to Say About McKesson
Within the last quarter, McKesson (NYSE:MCK) has observed the following analyst ratings: 
Via Benzinga
Why Rogers Shares Are Trading Sharply Lower; Here Are 33 Stocks Moving Premarket
Gainers Avinger, Inc. (NASDAQ: AVGR) rose 32% to $1.36 in pre-market trading. Avinger is expected to release its financial results for the third quarter on Wednesday, November 9, 2022. 
Via Benzinga
McKesson To $440? Plus This Analyst Raises PT On Fox
  Baird boosted the price target on McKesson Corporation (NYSE: MCK) from $405 to $440. McKesson shares fell 1.7% to $375.55 in pre-market trading. 
Via Benzinga
McKesson (MCK) Q2 2023 Earnings Call Transcript
MCK earnings call for the period ending September 30, 2022. 
Via The Motley Fool
Drug Behemoth McKesson Calls For Greater-Than-Expected Covid Windfall
The company now expects kitting and distributing vaccines to account for more profit. 
Via Investor's Business Daily
2 Buffett Stocks to Buy More Of In October
Buffett doesn't flee bear markets. And neither should we. 
Via The Motley Fool
McKesson Corporation Reports Fiscal 2023 Second-Quarter Results and Raises Full-Year Guidance
From McKesson Corporation
Via Business Wire
$100 Invested In McKesson 5 Years Ago Would Be Worth This Much Today
McKesson (NYSE:MCK) has outperformed the market over the past 5 years by 14.92% on an annualized basis producing an average annual return of 23.29%. Currently, McKesson has a market capitalization of... 
Via Benzinga
The 7 Best Boring Stocks to Buy for Red-Hot Returns
The best boring stocks come in all shapes and sizes. Here are seven you’ll want to consider for your “boring” portfolio. 
Via InvestorPlace
Ethereum Versus The S&P 500 - Where Should You Focus?
The answer if you consider yourself an investor is both.  The mistake people often make is obsessing over a single asset or asset class, drastically reducing their chances of making consistent... 
Via Benzinga
3 Warren Buffett Stocks That Should Beat the Market During a Recession
With fears of a recession rising, two of the three are already outperforming the S&P 500. 
Via The Motley Fool
Warren Buffett's Buying This Passive Income Stock
You should have this blue chip healthcare stock on your radar. 
Via The Motley Fool
McKesson Buys Rx Savings Solutions For $875M
Via Benzinga
Earnings Scheduled For November 1, 2022
Companies Reporting Before The Bell • BP (NYSE:BP) is estimated to report quarterly earnings at $2.07 per share on revenue of $64.76 billion. 
Via Benzinga
McKesson Corporation Declares Quarterly Dividend
From McKesson Corporation
Via Business Wire
Warren Buffett's Buying This Passive Income Stock: Should You?
McKesson delivered share price gains and passive income so far this year. 
Via The Motley Fool
'Right Now I Don't Want To Back Away From It,' Jim Cramer Says About This Stock Down Only 8% This Year
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he doesn’t want to back away from Iron Mountain Incorporated (NYSE: IRM) right now. "We may have to do new work on Iron Mountain to see if it’s as... 
Via Benzinga
5 Solid Dividend Growth Stocks For Q4
Five dividend growth stocks that could be compelling picks amid market volatility. 
Via Talk Markets
S&P 500 Biotech Giant Vertex Leads 5 Stocks Showing Strength
Vertex and LNG play Cheniere Energy are setting up bullishly. 
Via Investor's Business Daily
Is This Buffett-Backed Blue Chip Stock a Buy?
Berkshire Hathaway increased its stake in this healthcare stock by 9.5% in the second quarter. 
Via The Motley Fool
Cardinal Health Clears Base, But Can It Maintain Uptrend?
Cardinal Health, which distributes branded and generic pharmaceuticals and other healthcare products, cleared a cup-with-handle buy point Wednesday. 
Via MarketBeat
Why Ticker Symbols Mean Very Little: Three Tech Giants Versus An Obscure Stock
The S&P 500 continues to do battle with the weekly 200 simple moving average, a critical level that will determine if we see a repeat of 2000 and 2008 or a revival of a bull market.  
Via Benzinga
7 Warren Buffett Stocks to Buy and Hold for the Next Decade
Intelligent investors know that purchasing Warren Buffett stocks to buy and hold will work in the long-term. 
Via InvestorPlace
3 Stocks to Add to Your Portfolio in the Market Downturn
All three companies have easily surpassed the S&P 500 average this year. 
Via The Motley Fool
ZoomInfo Technologies, McKesson And This Restaurant Stock Insiders Are Selling
US crude oil futures traded lower this morning on Thursday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
McKesson Corporation Extends Pharmaceutical Distribution Agreement With CVS Health
From McKesson Corporation
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
3 Medical Stocks Displaying Remarkable Relative Strength In 2022
3 medical stocks that displayed a substantial amount of relative strength year-to-date. 
Via Talk Markets
S&P 500 Giant Leads 5 Stocks Showing Strength In Bear Market
Eli Lilly leads medical stocks setting up and showing relative strength. 
Via Investor's Business Daily
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.